LANXESS AG

LX9B

Equity

ISIN US5165571051 / Valor 12344600

Deutsche Boerse AG (2024-12-23)

EUR 4.44-0.89%

LANXESS AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

LANXESS AG is a leading specialty chemicals company headquartered in Cologne, with a global presence in 32 countries and approximately 12,800 employees. The company's core business involves the development, manufacturing, and marketing of chemical intermediates, additives, and consumer protection products, generating annual sales of EUR 6.7 billion. LANXESS operates through three segments: Advanced Industrial Intermediates, Specialty Additives, and Consumer Protection, encompassing 10 Business Units that cater to various applications and markets. The company prides itself on being a specialist and efficient partner, offering solutions to its customers' challenges while maintaining a strong commitment to quality in all aspects of its operations. LANXESS's global network enables it to provide local service and optimal procurement security, with its process management certified under international standards such as ISO 9001 and ISO 14001.

Summarized from source with an LLMView SourceSector: Industrials

Revenue Growth

In Q1 2024, LANXESS AG reported a sequential sales increase of 12%, reaching €1,607 million compared to €1,436 million in Q4 2023. This growth was primarily driven by a 13% rise in volumes, with only slight declines in prices.

EBITDA Performance

LANXESS AG's EBITDA pre-exceptionals for Q1 2024 showed a sequential improvement of 4%, amounting to €101 million, up from €97 million in Q4 2023. However, this figure still represents a significant year-over-year decline from €189 million in Q1 2023.

Profitability Challenges

Despite the sequential improvements, LANXESS AG's net income for Q1 2024 was reported at a loss of €98 million, a substantial drop from the €44 million loss recorded in Q1 2023. This decline was attributed to weaker operational performance and non-cash effects from Envalior’s at-equity contribution.

Segment Performance

The Consumer Protection segment experienced a 21% year-over-year decline in sales, with Q1 2024 sales at €509 million compared to €647 million in Q1 2023. This was largely due to intensified agro destocking and limited supply issues in the F&F business.

Outlook

LANXESS AG has provided a positive outlook for the remainder of 2024, expecting EBITDA pre-exceptionals to grow by 10-20% for the full year. The company anticipates sequential increases in EBITDA pre-exceptionals in Q2 and Q3, with further improvements expected in Q4 due to normal seasonality.

Summarized from source with an LLMView Source

Key figures

-18.5%1Y

%3Y

%5Y

Performance

45.8%1Y

52.6%3Y

52.6%5Y

Volatility